10.1186/s40694-018-0050-9 [DOI] [PMC free article] [PubMed] [Google Scholar] Stephens, N
This appetite effect remains consistent throughout treatment
Cellular processes linking hepatic injury and inflammation to oncogenesis, highlighting DAMP/SASP signaling and cytokine-mediated mitogenic pathways
Events including rash, apnea, drowsiness, poor sucking, and poor weight gain (requiring hospitalization in some cases) have been reported in infants who have been human milk-fed by mothers using lamotrigine
There are a few scenarios when GLP-1 treatment might be adjusted or discontinued, but for most people, GLP-1 medications are part of a long-term treatment strategy
Abstract There is increasing concern about the development of pancreatitis in patients with diabetes mellitus who received long-term glucagon-like peptide-1 (GLP-1) analog treatment